Epstein Secrets

n guarantee so that the Serum Institute of India could move ahead with production of "doses of promising coronavirus vaccines for the world's poor." Gates "has consulted frequently with" Dr. Fauci and Senate Majority Leader McConnell, "a polio survivor who has been supportive of programs to eradicate

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

y Fund Update and scientific deep-dive with Bill Gates Kate Bingham, Managing Partner +44 20 7421 7058,

National Institute of / Neurological Disorders and Stroke iDSZ,Z;:,::S of Hc-,a;:r, ) MID National Institute on Aging 41. 1.'141 Cure AD Fund Merck Scholars Program Ellison Foundation Dana Foundation Smith Family Foundation as EFTA00799268 Agenda Dementia Discovery :.•• : Fund •.•: •

guarantee so that the Serum Institute of India could move ahead with production of "doses of promising coronavirus vaccines for the world's poor." Gates "has consulted frequently with" Dr. Fauci and Senate Majority Leader McConnell, "a polio survivor who has been supportive of programs to eradicate t

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

ting EFTA_R1_02010997 EFTA02686123 William H. Gates Melinda Gates Gatot Mudiantoro Suwondo Kather

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

ef Executive Officer ANa Mexico Melinda French Gates Co-Chair Bill & Melinda Gates USA Foundation

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

ef Executive Officer ANa Mexico Melinda French Gates Co-Chair Bill & Melinda Gates USA Foundation

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

Spotify Ltd Germany USA Sweden Bill & Melinda Gates USA Foundation Head NV United Kingdom Studio

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola